Algae-based oral recombinant vaccines

Frontiers in Microbiology

Volumn 5, Issue FEB, 2014, Pages

  Specht, Elizabeth A ^a   Mayfield, Stephen P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Algal engineering; Microalgae; Oral vaccines; Plant produced vaccines; Recombinant subunit vaccines

Indexed keywords

ANGIOTENSIN II; CHOLERA TOXIN B SUBUNIT; FIBRONECTIN BINDING PROTEIN; GANGLIOSIDE GM1; GLUTAMATE DECARBOXYLASE 65; GLYCOPROTEIN E2; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; HYBRID PROTEIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; PARASITE ANTIGEN; PROTEIN E7; PROTEIN VP1; RECOMBINANT PROTEIN; RECOMBINANT VACCINE; STARCH SYNTHASE; SUBUNIT VACCINE; UNCLASSIFIED DRUG; VP 28 PROTEIN;

ANTIBODY RESPONSE; ANTIGENICITY; BIOENGINEERING; CHLAMYDOMONAS REINHARDTII; CHLOROPLAST; CROP; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENETIC TRANSFORMATION; HUMAN; IMMUNOREACTIVITY; MICROALGA; NONHUMAN; PROTEIN EXPRESSION; SHORT SURVEY; TABLET; TRANSGENE; VACCINATION; VACCINE PRODUCTION; WESTERN BLOTTING;

EID: 84897615391     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2014.00060     Document Type: Short Survey

References (41)

1. Chebolu, S., and Daniell, H. (2009). "Chloroplast-derived vaccine antigens and biopharmaceuticals: expression, folding, assembly and functionality," in Plant-Produced Microbial Vaccines, ed. A.V. Karasev. (Berlin: Springer-Verlag Berlin), 33-54. doi: 10.1007/978-3-540-70868-1_3
2. Dauvillée, D., Delhaye, S., Gruyer, S., Slomianny, C., Moretz, S. E., D'Hulst, C., et al. (2010). Engineering the chloroplast targeted malarial vaccine antigens in Chlamydomonas starch granules. PLoS ONE 5:e15424. doi: 10.1371/journal.pone.0015424
3. Demurtas, O. C., Massa, S., Ferrante, P., Venuti, A., Franconi, R., and Giuliano, G. (2013). A Chlamydomonas-derived human papillomavirus 16 E7 vaccine induces specific tumor protection. PLoS ONE 8:e61473. doi: 10.1371/journal.pone.0061473
4. Dreesen, I. A., Charpin-El Hamri, G., and Fussenegger, M. (2010). Heat-stable oral alga-based vaccine protects mice from Staphylococcus aureus infection. J. Biotechnol. 145, 273-280. doi: 10.1016/j.jbiotec.2009.12.006
5. Ducat, D. C., Way, J. C., and Silver, P. A. (2011). Engineering cyanobacteria to generate high-value products. Trends Biotechnol. 29, 95-103. doi: 10.1016/j.tibtech.2010.12.003
6. Fauci, A. S., Touchette, N. A., and Folkers, G. K. (2005). Emerging infectious diseases: a 10-year perspective from the national institute of allergy and infectious diseases. Emerg. Infect. Dis. 11, 519-525. doi: 10.3201/eid1104.041167
7. Franconi, R., Demurtas, O. C., and Massa, S. (2010). Plant-derived vaccines and other therapeutics produced in contained systems. Expert Rev. Vaccines 9, 877-892. doi: 10.1586/erv.10.91
8. Franklin, S. E., and Mayfield, S. P. (2005). Recent developments in the production of human therapeutic proteins in eukaryotic algae. Expert Opin. Biol. Ther. 5, 225-235. doi: 10.1517/14712598.5.2.225
9. Franklin, S., Ngo, B., Efuet, E., and Mayfield, S. P. (2002). Development of a GFP reporter gene for Chlamydomonas reinhardtii chloroplast. Plant J.Cell Mol. Biol. 30, 733-744. doi: 10.1046/j.1365-313X.2002.01319.x
10. Geng, D. G., Wang, Y. Q., Wang, P., Li, W. B., and Sun, Y. R. (2003). Stable expression of hepatitis B surface antigen gene in Dunaliella salina (Chlorophyta). J. Appl. Phycol. 15, 451-456. doi: 10.1023/B:JAPH.0000004298.89183.e5
11. Georgianna, D. R., and Mayfield, S. P. (2012). Exploiting diversity and synthetic biology for the production of algal biofuels. Nature 488, 329-335. doi: 10.1038/nature11479
12. Gong, Y., Hu, H., Gao, Y., Xu, X., and Gao, H. (2011). Microalgae as platforms for production of recombinant proteins and valuable compounds: progress and prospects. J. Ind. Microbiol. Biotechnol. 38, 1879-1890. doi: 10.1007/s10295-011-1032-6
13. Gowda, D. C., and Davidson, E. A. (1999). Protein glycosylation in the malaria parasite. Parasitol. Today 15, 147-152. doi: 10.1016/S0169-4758(99)01412-X
14. Gregory, J. A., Li, F., Tomosada, L. M., Cox, C. J., Topol, A. B., Vinetz, J. M., et al. (2012). Algae-produced Pfs25 elicits antibodies that inhibit malaria transmission. PLoS ONE 7:e37179. doi: 10.1371/journal.pone.0037179
15. Gregory, J. A., Topol, A. B., Doerner, D. Z., and Mayfield, S. (2013). Alga-produced cholera toxin-pfs25 fusion proteins as oral vaccines. Appl. Environ. Microbiol. 79, 3917-3925. doi: 10.1128/AEM.00714-13
16. Guan, Z. J., Guo, B., Huo, Y. L., Guan, Z. P., Dai, J. K., and Wei, Y. H. (2013). Recent advances and safety issues of transgenic plant-derived vaccines. Appl. Microbiol. Biotechnol. 97, 2817-2840. doi: 10.1007/s00253-012-4566-2
17. He, D. M., Qian, K. X., Shen, G. F., Zhang, Z. F., Li, Y. N., Su, Z. L., et al. (2007). Recombination and expression of classical swine fever virus (CSFV) structural protein E2 gene in Chlamydomonas reinhardtii chroloplasts. Colloids Surf. B Biointerfaces 55, 26-30. doi: 10.1016/j.colsurfb.2006.10.042
18. Hempel, F., Lau, J., Klingl, A., and Maier, U. G. (2011). Algae as protein factories: expression of a human antibody and the respective antigen in the diatom Phaeodactylum tricornutum. PLoS ONE 6:e28424. doi: 10.1371/journal.pone.0028424
19. Jacob, S. S., Cherian, S., Sumithra, T. G., Raina, O. K., and Sankar, M. (2013). Edible vaccines against veterinary parasitic diseases-current status and future prospects. Vaccine 31, 1879-1885. doi: 10.1016/j.vaccine.2013.02.022
20. Jones, C. S., Luong, T., Hannon, M., Tran, M., Gregory, J. A., Shen, Z., et al. (2013). Heterologous expression of the C-terminal antigenic domain of the malaria vaccine candidate Pfs48/45 in the green algae Chlamydomonas reinhardtii. Appl. Microbiol. Biotechnol. 97, 1987-1995. doi: 10.1007/s00253-012-4071-7
21. Khan, I., Twyman, R. M., Arcalis, E., and Stoger, E. (2012). Using storage organelles for the accumulation and encapsulation of recombinant proteins. Biotechnol. J. 7, 1099-1108. doi: 10.1002/biot.201100089
22. Kwon, K. C., Verma, D., Singh, N. D., Herzog, R., and Daniell, H. (2013). Oral delivery of human biopharmaceuticals, autoantigens and vaccine antigens bioencapsulated in plant cells. Adv. Drug Deliv. Rev. 65, 782-799. doi: 10.1016/j.addr.2012.10.005
23. Lossl, A. G., and Waheed, M. T. (2011). Chloroplast-derived vaccines against human diseases: achievements, challenges and scopes. Plant Biotechnol. J. 9, 527-539. doi: 10.1111/j.1467-7652.2011.00615.x
24. Manuell, A. L., Beligni, M. V., Elder, J. H., Siefker, D. T., Tran, M., Weber, A., et al. (2007). Robust expression of a bioactive mammalian protein in Chlamydomonas chloroplast. Plant Biotechnol. J. 5, 402-412. doi: 10.1111/j.1467-7652.2007.00249.x
25. Martinez, C. A., Giulietti, A. M., and Talou, J. R. (2012). Research advances in plant-made flavivirus antigens. Biotechnol. Adv. 30, 1493-1505. doi: 10.1016/j.biotechadv.2012.03.004
26. Mason, H.S., and Herbst-Kralovetz, M. M. (2012). "Plant-derived antigens as mucosal vaccines," in Mucosal Vaccines: Modern Concepts, Strategies, and Challenges, ed. P. A. Kozlowski (Berlin: Springer-Verlag Berlin), 101-120. doi: 10.1007/82_2011_158
27. Pelosi, A., Shepherd, R., and Walmsley, A. M. (2012). Delivery of plant-made vaccines and therapeutics. Biotechnol. Adv. 30, 440-448. doi: 10.1016/j.biotechadv.2011.07.018
28. Qin, S., Lin, H., and Jiang, P. (2012). Advances in genetic engineering of marine algae. Biotechnol. Adv. 30, 1602-1613. doi: 10.1016/j.biotechadv.2012.05.004
29. Rasala, B. A., and Mayfield, S. P. (2011). The microalga Chlamydomonas reinhardtii as a platform for the production of human protein therapeutics. Bioeng. Bugs 2, 50-54. doi: 10.4161/bbug.2.1.13423
30. Rasala, B. A., Muto, M., Lee, P. A., Jager, M., Cardoso, R. M., Behnke, C. A., et al. (2010). Production of therapeutic proteins in algae, analysis of expression of seven human proteins in the chloroplast of Chlamydomonas reinhardtii. Plant Biotechnol. J. 8, 719-733. doi: 10.1111/j.1467-7652.2010.00503.x
31. Rasala, B. A., Muto, M., Sullivan, J., and Mayfield, S. P. (2011). Improved heterologous protein expression in the chloroplast of Chlamydomonas reinhardtii through promoter and 5' untranslated region optimization. Plant Biotechnol. J. 9, 674-683. doi: 10.1111/j.1467-7652.2011.00620.x
32. Rosales-Mendoza, S., Govea-Alonso, D. O., Monreal-Escalante, E., Fragoso, G., and Sciutto, E. (2012a). Developing plant-based vaccines against neglected tropical diseases: where are we? Vaccine 31, 40-48. doi: 10.1016/j.vaccine.2012.10.094
33. Rosales-Mendoza, S., Rubio-Infante, N., Govea-Alonso, D. O., and Moreno-Fierros, L. (2012b). Current status and perspectives of plant-based candidate vaccines against the human immunodeficiency virus (HIV). Plant Cell Rep. 31, 495-511. doi: 10.1007/s00299-011-1194-8
34. Rybicki, E. P. (2009). Plant-produced vaccines: promise and reality. Drug Discov. Today 14, 16-24. doi: 10.1016/j.drudis.2008.10.002
35. Soria-Guerra, R. E., Ramírez-Alonso, J. I., Ibáñez-Salazar, A., Govea-Alonso, D. O., Paz-Maldonado, L. M. T., Bañuelos-Hernández, B., et al. (2014). Expression of an HBcAg-based antigen carrying angiotensin II in Chlamydomonas reinhardtii as a candidate hypertension vaccine. Plant Cell Tissue Organ Cult. 116, 133-139. doi: 10.1007/s11240-013-0388-x
36. Specht, E. A., and Mayfield, S. P. (2013). Synthetic oligonucleotide libraries reveal novel regulatory elements in Chlamydomonas chloroplast mRNAs. ACS Synth. Biol. 2, 34-46. doi: 10.1021/sb300069k
37. Sun, M., Qian, K. X., Su, N., Chang, H. Y., Liu, J. X., and Chen, G. F. (2003). Foot-and-mouth disease virus VP1 protein fused with cholera toxin B subunit expressed in Chlamydomonas reinhardtii chloroplast. Biotechnol. Lett. 25, 1087-1092. doi: 10.1023/A:1024140114505
38. Surzycki, R., Greenham, K., Kitayama, K., Dibal, F., Wagner, R., Rochaix, J. D., et al. (2009). Factors effecting expression of vaccines in microalgae. Biologicals 37, 133-138. doi: 10.1016/j.biologicals.2009.02.005
39. Tran, M., Zhou, B., Pettersson, P. L., Gonzalez, M. J., and Mayfield, S. P. (2009). Synthesis and assembly of a full-length human monoclonal antibody in algal chloroplasts. Biotechnol. Bioeng. 104, 663-673. doi: 10.1002/bit.22446
40. Wang, X., Brandsma, M., Tremblay, R., Maxwell, D., Jevnikar, A. M., Huner, N., et al. (2008). A novel expression platform for the production of diabetes-associated autoantigen human glutamic acid decarboxylase (hGAD65). BMC Biotechnol. 8:87. doi: 10.1186/1472-6750-8-87
41. Wigdorovitz, A., Carrillo, C., Dus Santos, M. J., Trono, K., Peralta, A., Gomez, M. C., et al. (1999). Induction of a protective antibody response to foot and mouth disease virus in mice following oral or parenteral immunization with alfalfa transgenic plants expressing the viral structural protein VP1. Virology 255, 347-353. doi: 10.1006/viro.1998.9590